Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

Adult growth hormone deficiency (AGHD) is associated with an increased risk of cardiovascular (CV) disease. Long-term growth hormone (GH) treatment could improve CV outcomes. The objective of this study was to evaluate CV disease risk in patients with AGHD who received GH replacement therapy for up...

Descripción completa

Detalles Bibliográficos
Autores principales: Höybye, Charlotte, Biller, Beverly M K, Ferran, Jean-Marc, Gordon, Murray B, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne H, Weber, Matthias M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782424/
https://www.ncbi.nlm.nih.gov/pubmed/36347049
http://dx.doi.org/10.1530/EC-22-0267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782424/
https://www.ncbi.nlm.nih.gov/pubmed/36347049
http://dx.doi.org/10.1530/EC-22-0267

Ejemplares similares